ISSN 2639-9431
Vol. 9, Issue 1, 2026February 19, 2026 EDT
Nanoparticles for brain disease: translational failures, blood-brain barrier heterogeneity, and precision design constraints
Nanoparticles for brain disease: translational failures, blood-brain barrier heterogeneity, and precision design constraints
Arun Kumar Nirmal, Btech, Mtech (candidate), Haripriya Dayalan, Ph.D, Rohith S, Btech, Mtech (candidate), Gayathri Ayyar, Btech (candidate),
Nanoparticlesblood–brain barrierbrain-related diseasesnanomedicinetargeted drug deliverytheranosticsbiomimetic nanoparticlesclinical translation
Articles in Vol. 9, Issue 1, 2026
Vol. 9, Issue 1, 2026
- Evaluating Indigenous Lytic Bacteriophages for Activity Against Multi-Resistant EnterobacteriaceaeEbele B. OnuigboStephen Chijioke EmenchetaChinonye EneovoEmmanuel ArinzeMaria NgwuMarie U. E. DibuaAnthony A. Attama
- Irisin-loaded Porous Silica Nanoparticles Enhance Bone Healing in High Cholesterol Diet-induced Medaka Fish ModelPrashant SadanandanSilja KrishnanManzoor KoyakuttyManitha Nair
- Nanoparticles for brain disease: translational failures, blood-brain barrier heterogeneity, and precision design constraintsArun Kumar NirmalHaripriya DayalanRohith SGayathri Ayyar
- Nanomaterials as a promising platform for COVID-19Mohammad Hosein Fathian NasabMohammad Amin ManaviMohammad HamrahiFatemeh KhonsariMohaddeseh GelivarisarshariAryan ForoohariMohammad DehghaniSheyda RanjbarFatemeh Atyabi
1.
Nirmal AK, Dayalan H, S R, Ayyar G. Nanoparticles for brain disease: translational failures, blood-brain barrier heterogeneity, and precision design constraints. Precis Nanomed. 2026;9(1):1746-1766. doi:10.33218/001c.157822